Sio Capital Management, LLC Travere Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

  • $189 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$7.64 - $17.25 $6.76 Million - $15.3 Million
884,770 New
884,770 $7.91 Million
Q3 2021

Nov 15, 2021
SELL
$12.98 - $25.03 $1.95 Million - $3.75 Million
-150,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$14.11 - $26.4 $2.12 Million - $3.96 Million
150,000 New
150,000 $2.19 Million

Others Institutions Holding TVTX

# of Institutions
192
Shares Held
84.5M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.12B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email